ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Higher Heavy Metal Blood Levels in Men with Idiopathic Hypogonadotropic Hypogonadism (IHH)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 274619" data-attributes="member: 3"><p>Idiopathic Hypogonadotropic Hypogonadism (IHH) is a condition characterized by delayed or absent sexual development due to low levels of sex hormones. It is also known as isolated gonadotropin-releasing hormone (GnRH) deficiency. IHH can be congenital or acquired and is often associated with anosmia (lack of sense of smell), a condition known as Kallmann syndrome. The prevalence of idiopathic hypogonadotropic hypogonadism is approximately 1 in 10,000 men. It can manifest as small testes, a short penis, and delayed or absent puberty in males. The condition may be caused by gene mutations in KAL-1, FGFR1, GnRHR, GPR54, among others. Treatment options include hormone replacement therapy to induce and maintain secondary sexual characteristics and fertility. Early diagnosis and management are important to minimize patient morbidity.</p><p></p><p>STUDY:</p><p>The diagnostic criteria employed for isolated idiopathic hypogonadotropic hypogonadism in males included the following: (a) the absence of pubertal development by the age of 18, (b) serum testosterone level ≤ 100 ng/dl with low serum gonadotropin levels in the first visit; (c) other anterior pituitary hormone levels remaining normal; and (d) no abnormalities in hypothalamic-pituitary region magnetic resonance imaging. This cross-sectional study enrolled 26 male patients with a mean age (standard deviation) of 28.1 (8.4) with IHH and 22 healthy males with a mean age (standard deviation) of 31.5 (9.8) who visited the Endocrinology Outpatient Clinic of Erzurum Training and Research Hospital between May 2023 and December 2023. No genetic mutation was found in the genetic analysis performed on patients with isolated hypogonadotropic hypogonadism. </p><p></p><p>Abstract</p><p>Introduction: The toxic effects of heavy metals on biological systems are being investigated with increasing interest day by day. Our purpose was to investigate heavy metals such as aluminum (Al), cadmium (Cd), arsenic (As), lead (Pb), and nickel (Ni) in males with idiopathic hypogonadotropic hypogonadism (IHH) and to determine whether there is a relationship between heavy metals and testosterone levels.</p><p></p><p>Methods: Twenty-six male patients with IHH aged 18-50 and 22 healthy males aged 21-50 admitted to the Outpatient Department of Endocrinology for follow-up were enrolled. BMIs were calculated by measuring the height and weight of all participants. Al, Cd, As, Pb, and Ni levels were measured and compared between groups. Testosterone levels were measured to investigate whether there was a correlation with heavy metal levels.</p><p></p><p>Results: <strong>Al, Cd, As, Pb, and Ni levels were statistically higher in the patient group compared to the control group (p<0.001). A moderately strong significant negative correlation was detected between the patients' testosterone and As levels (p=0.001, r=-0.609, R2=0.371). Decreased As and Cd levels were observed as the patients’ ages increased (p=0.013, r=-0.471).</strong></p><p></p><p>Conclusion: Heavy metals might play potential roles in IHH. We hope that investigating heavy metal levels in IHH and adding toxicity-preventive treatments to hormonal therapies will be beneficial in the multifaceted management of the disease in clinical practice.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 274619, member: 3"] Idiopathic Hypogonadotropic Hypogonadism (IHH) is a condition characterized by delayed or absent sexual development due to low levels of sex hormones. It is also known as isolated gonadotropin-releasing hormone (GnRH) deficiency. IHH can be congenital or acquired and is often associated with anosmia (lack of sense of smell), a condition known as Kallmann syndrome. The prevalence of idiopathic hypogonadotropic hypogonadism is approximately 1 in 10,000 men. It can manifest as small testes, a short penis, and delayed or absent puberty in males. The condition may be caused by gene mutations in KAL-1, FGFR1, GnRHR, GPR54, among others. Treatment options include hormone replacement therapy to induce and maintain secondary sexual characteristics and fertility. Early diagnosis and management are important to minimize patient morbidity. STUDY: The diagnostic criteria employed for isolated idiopathic hypogonadotropic hypogonadism in males included the following: (a) the absence of pubertal development by the age of 18, (b) serum testosterone level ≤ 100 ng/dl with low serum gonadotropin levels in the first visit; (c) other anterior pituitary hormone levels remaining normal; and (d) no abnormalities in hypothalamic-pituitary region magnetic resonance imaging. This cross-sectional study enrolled 26 male patients with a mean age (standard deviation) of 28.1 (8.4) with IHH and 22 healthy males with a mean age (standard deviation) of 31.5 (9.8) who visited the Endocrinology Outpatient Clinic of Erzurum Training and Research Hospital between May 2023 and December 2023. No genetic mutation was found in the genetic analysis performed on patients with isolated hypogonadotropic hypogonadism. Abstract Introduction: The toxic effects of heavy metals on biological systems are being investigated with increasing interest day by day. Our purpose was to investigate heavy metals such as aluminum (Al), cadmium (Cd), arsenic (As), lead (Pb), and nickel (Ni) in males with idiopathic hypogonadotropic hypogonadism (IHH) and to determine whether there is a relationship between heavy metals and testosterone levels. Methods: Twenty-six male patients with IHH aged 18-50 and 22 healthy males aged 21-50 admitted to the Outpatient Department of Endocrinology for follow-up were enrolled. BMIs were calculated by measuring the height and weight of all participants. Al, Cd, As, Pb, and Ni levels were measured and compared between groups. Testosterone levels were measured to investigate whether there was a correlation with heavy metal levels. Results: [B]Al, Cd, As, Pb, and Ni levels were statistically higher in the patient group compared to the control group (p<0.001). A moderately strong significant negative correlation was detected between the patients' testosterone and As levels (p=0.001, r=-0.609, R2=0.371). Decreased As and Cd levels were observed as the patients’ ages increased (p=0.013, r=-0.471).[/B] Conclusion: Heavy metals might play potential roles in IHH. We hope that investigating heavy metal levels in IHH and adding toxicity-preventive treatments to hormonal therapies will be beneficial in the multifaceted management of the disease in clinical practice. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Higher Heavy Metal Blood Levels in Men with Idiopathic Hypogonadotropic Hypogonadism (IHH)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top